A new study has verified the link between the hormone drospirenone, found in the birth control pill Yaz, and an increased risk for venous thromboembolism (VTE), or blood clots in the lungs. Manufactured by Bayer, Yaz contains the progestin drospirenone. The same hormone is also used in Bayer’s birth control pills Yasmin, Beyaz and Safyral, as well as generics such as Ocella, Gianvi, Loryna, Syeda and Zarah.  The study showed the risk for VTE is as much as two to three times higher with drospirenone-containing pills than in pills with other hormone variations. As a result of the study, the FDA has issued a special drug safety notification regarding the hormone.

This material is for informational purposes only and does not constitute legal advice. No representation is made that the quality of legal services to be performed is greater than the quality of legal services performed by other lawyers.

About Legal Briefs
Legal Briefs addresses various topics of public interest including recalls, public safety, breaking news and important verdicts and settlements. These episodes of "Legal Briefs" brought to you by Lauren Thompson, help keep the public informed, raise awareness and promote safety and justice.

Recorded: June 10, 2011

Courtesy of: BEASLEY ALLEN

Keywords: Pharmaceutical, Yaz